What Cosmos Health Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 1 | 21 |
| Sells | 0 | 0 |
| Total trades | 1 | 37 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
Common stock only — 37 reported trades in the last 12 months are in a security these totals do not cover.
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer | Jul 30 | Open-market buy · P | +349,825 | $0.20 | +$70K | 14,597,917 |
| Siokas Grigorios | Chief Executive Officer | Jul 29 | Open-market buy · P | +766,284 | $0.18 | +$140K | 14,248,092 |
| Terzis Georgios | Chief Financial Officer | Jul 29 | Grant / award · A | +328,407 | $0.18 | +$60K | 2,563,805 |
| Terzis Georgios | Chief Financial Officer | Jun 16 | Open-market buy · P | +168,135 | $0.25 | +$42K | 2,235,398 |
| Siokas Grigorios | Chief Executive Officer | Jun 11 | Open-market buy · P | +218,447 | $0.21 | +$45K | 13,481,808 |
| Siokas Grigorios | Chief Executive Officer | Jun 10 | Open-market buy · P | +701,447 | $0.23 | +$160K | 13,263,361 |
| Karkantzos Theodoros Christos | Director | May 19 | Grant / award · A | +20,000 | $0.28 | +$5.66K | 35,000 |
| Siokas Grigorios | Chief Executive Officer | May 19 | Grant / award · A | +2,350,000 | $0.28 | +$665K | 12,561,914 |
| Terzis Georgios | Chief Financial Officer | May 19 | Grant / award · A | +850,000 | $0.28 | +$241K | 2,067,263 |
| Bhutawala Suhel | Director | May 19 | Grant / award · A | +20,000 | $0.28 | +$5.66K | 65,000 |
| Demetriades Demetrios G. | Secretary | May 19 | Grant / award · A | +20,000 | $0.28 | +$5.66K | 55,000 |
| Hoidas John James | Director | May 19 | Grant / award · A | +20,000 | $0.28 | +$5.66K | 50,000 |
| Aslidis Anastasios | Director | May 19 | Grant / award · A | +40,000 | $0.28 | +$11.3K | 100,000 |
| Siokas Grigorios | Chief Executive Officer | Feb 12 | Open-market buy · P | +388,532 | $0.37 | +$145K | 8,861,914 |
| Siokas Grigorios | Chief Executive Officer | Feb 11 | Open-market buy · P | +291,262 | $0.41 | +$120K | 8,473,382 |
| Siokas Grigorios | Chief Executive Officer | Jan 23 | Open-market buy · P | +90,325 | $0.50 | +$45K | 8,182,120 |
| Siokas Grigorios | Chief Executive Officer | Jan 20 | Open-market buy · P | +353,321 | $0.50 | +$175K | 8,091,795 |
| Siokas Grigorios | Chief Executive Officer | Jan 14 | Open-market buy · P | +493,495 | $0.45 | +$220K | 7,738,474 |
| Siokas Grigorios | Chief Executive Officer | Jan 12 | Open-market buy · P | +113,185 | $0.50 | +$57K | 7,244,979 |
| Siokas Grigorios | Chief Executive Officer | Jan 08 | Open-market buy · P | +156,190 | $0.52 | +$81K | 7,131,794 |
Loading...
